Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
159.27
-0.69 (-0.43%)
Jan 2, 2026, 4:00 PM EST - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $5.97 billion as of January 5, 2026. Its market cap has increased by 206.65% in one year.
Market Cap
5.97B
Enterprise Value
5.70B
1-Year Change
206.65%
Ranking
Category
Stock Price
$159.27
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $5.97B, an increase of 4,032.86%. That is a compound annual growth rate of 174.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 5.97B | -0.43% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |